Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

Rheuminations: Road to Success in Medicine May Be Paved with Failure

Simon M. Helfgott, MD  |  February 1, 2014

How healthcare has benefited from breakthrough discoveries related to bovine spongiform encephalitis, H. pylori ulcer disease, and properdin by researchers who persevered despite criticism from skeptics

Filed under:Career DevelopmentEducation & TrainingOpinionProfessional TopicsResearch RheumRheuminationsSpeak Out Rheum Tagged with:anti-inflammatorydiscoveryHelfgottHistoryResearchrheumatologist

2013 ACR/ARHP Annual Meeting: Better Care for Pediatric Rheumatology Patients On Horizon

Susan Bernstein  |  February 1, 2014

A robust workforce, flourishing clinical trials, broad patient registries, and consensus treatment protocols contribute to improvements for the subspecialty

Filed under:Career DevelopmentConditionsEducation & TrainingMeeting ReportsProfessional TopicsResearch RheumRheumatoid Arthritis Tagged with:ACR/ARHP Annual Meetingpatient carePediatric RheumatologyPediatricsResearchRheumatoid arthritisrheumatologist

Does Anti-Tumor Necrosis Factor-Alpha Increase Cardiovascular Burden?

Lara C. Pullen, PhD  |  January 14, 2014

Long-term use of TNFα inhibitors in patients with rheumatoid arthritis and ankylosing spondylitis is associated with both gains in fat mass and a shift in fat mass to the visceral region.  (posted Jan. 14)

Filed under:Axial SpondyloarthritisConditionsResearch Rheum Tagged with:Ankylosing SpondylitisCardiovascular diseaseRheumatoid arthritisTNFtumor necrosis factor

Rheumatologists On The Move

Caitlin Cromley  |  January 1, 2014

Awards, appointments, and announcements in the world of rheumatology

Filed under:ConditionsLegislation & AdvocacyOsteoarthritis and Bone DisordersProfessional TopicsProfilesResearch RheumSystemic Lupus Erythematosus Tagged with:AdvocacyAwardsLupusMovers & ShakersOsteoarthritisProfileResearchrheumatologist

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  January 1, 2014

Information on new approvals and medication safety that rheumatologists need to know

Filed under:Axial SpondyloarthritisBiologics/DMARDsConditionsDrug UpdatesResearch RheumRheumatoid Arthritis Tagged with:Ankylosing Spondylitisanti-inflammatoryApprovalsaxial spondyloarthritis (SpA)BiologicsdrugFDAMethotrexateResearchRheumatoid arthritisrheumatologistrheumatologySafetytocilizumab

Fellow’s Forum Case Report: Arthritis, Fever, and Weight Loss In a Teenager Suggest A Rheumatic Condition

Jonathan S. Hausmann, MD  |  January 1, 2014

Joint pain and swelling flare up in a 14-year-old boy who tests positive for inflammation, thrombocytosis, and human leukocyte antigen B27

Filed under:Axial SpondyloarthritisConditionsPediatric ConditionsRheumatoid Arthritis Tagged with:anti-inflammatoryautoinflammatoryClinicalDiagnosisdrugfeverlabsMethotrexatepatient carePediatricprednisoneReactive arthritistocilizumabweight loss

2013 ACR/ARHP Annual Meeting: Health Professionals In the Spotlight

Richard Quinn  |  January 1, 2014

ARHP members are honored with awards for research, education, advocacy, and patient care in rheumatology

Filed under:Legislation & AdvocacyMeeting ReportsProfessional TopicsProfiles Tagged with:ACR/ARHP Annual MeetingAdvocacyAssociation of Rheumatology Professionals (ARP)Awardsdrughealth professionalsPediatricsProfilerheumatologist

Rheuminations: Why the Obesity Epidemic Should Matter to Rheumatologists

Simon M. Helfgott, MD  |  January 1, 2014

As changes in diet and eating habits have caused obesity rates to soar, research into the metabolic syndrome suggests obesity may be a form of a low-grade inflammatory state

Filed under:OpinionResearch RheumRheuminationsSpeak Out Rheum Tagged with:anti-inflammatoryeatingepidemicHelfgottMethotrexateObesitypatient careResearchrheumatologistrheumatology

Affordable Care Act Latest in Half-Century of Healthcare Reform

Bryn Nelson, PhD  |  January 1, 2014

Highlights in 50-year timeline of national healthcare legislation, proposals, and policies since the Social Security Act was adopted in 1965

Filed under:InsuranceLegislation & AdvocacyProfessional Topics Tagged with:ACAAffordable Care Act (ACA)HealthcareHistoryinsuranceLegislationMedicareObamacarereformrheumatologist

What the Affordable Care Act Means for Rheumatology

Bryn Nelson, PhD  |  January 1, 2014

Expected to flood the healthcare system with an influx of insured patients, Obamacare will likely exacerbate physician shortages, worsen capacity issues for many rheumatologists, and pressure providers to deliver a measurable quality of care, but analysts say rheumatology patients will benefit from expanded insurance coverage options

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:ACAACOAffordable Care Act (ACA)druginsurance coverageLegislationMedicareObamacarepatient carephysician shortagerheumatologistrheumatology

  • « Previous Page
  • 1
  • …
  • 265
  • 266
  • 267
  • 268
  • 269
  • …
  • 326
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences